Osteoporosis disease is the most prevalent disease that occurs due to bone mineral density which causes heavy risk of fractures and bone fragility. The disease occurs mostly in spine, hip, shoulder and forearm.Hip fractures are most common as nearly one-third of patients lose mobility and need long-term nursing. As patients are unable to move, prolonged complications arising out of bed immobilization ultimately results into fatality. The diagnostic measures of osteoporosis include X-ray and radiography tests that are further acknowledged with bone density test.
Access research report on global anti-osteoporosis therapy and fracture healing market: http://www.grandviewresearch.com/industry-analysis/anti-osteoporosis-therapy-fracture-healing-market
Osteoporosis is more prevalent in geriatric women than men; hence the suggested treatment is known as anti-osteoporosis which is intended to increase the bone mineral density and keeps a control over loss of bone tissue. Anti-osteoporosis reduces the risk of fractures by significant percent.
Related reports by Grand View Research:
The medicines used against osteoporosis mainly contain bisphosphonate molecules. The anti-osteoporosis market and fracture healing market is thus projected to register a healthy CAGR during the forecast period. The driving factors responsible for the growth of anti-osteoporosis therapy and fracture healing market include increasing prevalence of osteoporosis in aged women, rise in incidence of osteoporosis patients andgrowing prevalence of bone diseases resulting out of changing lifestyle are some factors fueling the market growth.Additionally, growth in investments in R&D for generation of drugs and increasing awareness about osteoporosis are also adding to the growth of osteoporosis market.
However, factors like complications and side effects obtained from these therapies such as nausea, irritable bowel syndrome, symptoms of influenza,stomach ulcers and esophagus. Overall, the global anti-osteoporosis therapy and fracture healing market is projected to grow at a higher CAGR owing to efficiency of driving factors and increasing benefits of anti-osteoporosis therapies over other osteoporosis therapies. On the basis of administration, the global anti-osteoporosis therapy market includes oral and injectable.
Read Our Blogs –grandviewresearch.com/blogs/healthcare
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Corporate Sales Specialist, USA
Grand View Research, Inc
Toll Free: 1-888-202-9519
For more information: www.grandviewresearch.com